Jorge Vela-Ojeda

Years Active: 2020-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Jorge Vela-Ojeda, Ana Cristina Olivas-Bejarano, Laura Arcelia Montiel-Cervantes, Erika Rosales-Cruz, Socrates Garcia-Gutierrez, Ruth Angelica Lezama-Palacios, Elba Reyes-Maldonado
Soluble MIC-A, IPI, and response to treatment strongly predict survival in patients with germinal center diffuse large B cell lymphoma. European journal of haematology (2024)
Jorge Vela-Ojeda, Ana Cristina Olivas-Bejarano, Laura Arcelia Montiel-Cervantes, Erika Rosales-Cruz, Socrates Garcia-Gutierrez, Ruth Angelica Lezama-Palacios, Elba Reyes-Maldonado
Soluble MIC-A, IPI, and response to treatment strongly predict survival in patients with germinal center diffuse large B cell lymphoma. European journal of haematology 113 (3) (2024)
Ana Cristina Olivas-Bejarano, Laura Arcelia Montiel-Cervantes, Flor Del Carmen Perez-Retiguin, Socrates Garcia-Gutierrez, Teresita Rocio Cruz-Hernandez, Ruth Angelica Lezama-Palacios, Elba Reyes-Maldonado, Jorge Vela-Ojeda
Lymphocyte subsets and soluble forms of MIC-A and MIC-B are prognostic factors in non-Hodgkin lymphoma patients. Annals of hematology (2023)
Jorge Vela-Ojeda, Flor Del Carmen Perez-Retiguin, Ana Cristina Olivas-Bejarano, Miriam America Garcia-Ruiz Esparza, Jaime Garcia-Chavez, Abraham Majluf-Cruz, Elba Reyes-Maldonado, Laura Arcelia Montiel-Cervantes
Clinical relevance of NKT cells and soluble MIC-A in Hodgkin lymphoma. Leukemia & lymphoma 62 (4) (2020)

Jorge Vela-Ojeda.css-eqlu8i{font-size:small;padding-left:4px;}